Milk powder synthetic, low calcium oral powder

PBAC's latest decision on Milk powder synthetic, low calcium oral powder: Recommended (2024). Considered for Dietary management of hypercalcaemia in patients under 4 years of age.

Eligible population

Infants and children under 4 years of age requiring dietary management of hypercalcaemia.

Therapy area

Metabolic

Line of therapy

Not applicable

Evidence base

Other

Economic model

Not modelled

ICER note

No economic analysis performed; this is a formulation change submission with no change to price or listing conditions.

Similar precedents

• Milk powder synthetic low calcium
  similarity 0.98
• High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate
  similarity 0.61
• Triglycerides medium chain and long chain with glucose polymer
  similarity 0.59
• Sodium zirconium cyclosilicate
  similarity 0.59
• Milk powder - lactose intolerance formula
  similarity 0.59
• Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids; amino acid formula supplemented with prebiotics, probiotics and long chain polyunsaturated fatty acids
  similarity 0.59